Skip to main content
SpringerLink
Log in
Book cover

Single Agents in Cancer Chemotherapy pp 25–80Cite as

Cyclophosphamide

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arnold, H., Bourseaux, F., and Brock, N. Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester (B-518-ASTA) in experimental tumors of the rat. Nature 181: 931, 1958.

    Article  PubMed  CAS  Google Scholar 

  2. Foley, G., Friedman, O., and Drolet, B. Studies on the mechanism of action of Cytoxan. Evidence of activation in vivo and in vitro. Cancer Res 21: 57, 1961.

    PubMed  CAS  Google Scholar 

  3. Santos, G., Owens, A., and Sensenbrenner, L. Effects of selected cytotoxic agents on antibody production in man: a preliminary report. Ann NY Acad Sci 114: 404, 1964.

    Article  PubMed  CAS  Google Scholar 

  4. Cramblett, H. Experience with cyclophosphamide in treatment of childhood tumors. In “Antibiotics Annual, 1959–1960”, Antibiotica, Inc., New York; pp 966–969, 1960.

    Google Scholar 

  5. Haar, H., Marshall, J., Bierman, H., et al. The influence of cyclophosphamide upon neoplastic diseases in man. Cancer Chemother Rep 6: 41, 1960.

    PubMed  CAS  Google Scholar 

  6. Papac, R., Petrakis, N., Amini, F., et al. Comparative clinical evaluation of two alkylating agents — mannitol mustard and cyclophosphamide (Cytoxan). JAMA 172: 1387, 1960.

    Article  CAS  Google Scholar 

  7. Korst, D., Johnson, F., Frenkel, E., et al. Preliminary evaluation of the effect of cyclophosphamide on the course of human neoplasms. Cancer Chemother Rep 7: 1, 1960.

    Google Scholar 

  8. Bergsagel, D., and Levin, W. A prelusive clinical trial of cyclophosphamide. Cancer Chemother Rep 8: 120, 1960.

    PubMed  CAS  Google Scholar 

  9. Bethell, F., Louis, J., Robbins, A., et al. Phase II evaluation of cyclophosphamide. A study by the Midwest Cooperative Chemotherapy Group. Cancer Chemother Rep 8: 112, 1960.

    PubMed  CAS  Google Scholar 

  10. Shnider, B., Gold, G., Hall, T., et al. Preliminary studies with cyclophosphamide. Cancer Chemother Rep 8: 106, 1960.

    PubMed  CAS  Google Scholar 

  11. Spurr, C., and Hayes, D. Clinical observations on newer chemotherapeutic agents. South Med J 53: 1005, 1960.

    Article  PubMed  CAS  Google Scholar 

  12. Foye, L., Chapman, C., Willett, F., et al. Cyclophosphamide. A preliminary study of a new alkylating agent. Arch Intern Med 106: 365, 1960.

    Article  PubMed  Google Scholar 

  13. Coggins, P., Ravdin, R., and Eisman, S. Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide). Cancer 13: 1254, 1960.

    PubMed  CAS  Google Scholar 

  14. Hurley, J., Ellison, E., and Carey, L. Treatment of advanced cancer of the gastrointestinal tract with antitumor agents. Gastroenterology 41: 557, 1961.

    PubMed  CAS  Google Scholar 

  15. Kontras, S., and Newton, W. Cyclophosphamide (Cytoxan) therapy of childhood neuroblastoma. Preliminary report. Cancer Chemother Rep 12: 39, 1961.

    PubMed  CAS  Google Scholar 

  16. Wall, R., and Conrad, F. Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors. Arch Intern Med 108: 456, 1961.

    Article  PubMed  CAS  Google Scholar 

  17. Anders, C., and Kemp, N. Cyclophosphamide in treatment of disseminated malignant disease. Brit Med J 2: 1516, 1961.

    Article  PubMed  CAS  Google Scholar 

  18. Rundles, R., Laszlo, J., Garrison, F., et al. The antitumor spectrum of cyclophosphamide. Cancer Chemother Rep 16: 407, 1962.

    PubMed  CAS  Google Scholar 

  19. Laszlo, J., Grizzle, J., Jonsson, U., et al. Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas. Cancer Chemother Rep 16: 247, 1962.

    PubMed  CAS  Google Scholar 

  20. Spear, P., and Patno, M. A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin’s disease, and lymphosarcoma. Cancer Chemother Rep 16: 413, 1962.

    PubMed  CAS  Google Scholar 

  21. Atkins, H., Gregg, H., and Hyman, G. Clinical appraisal of cyclophosphamide in malignant neoplasms. Cancer 15: 1076, 1962.

    Article  PubMed  CAS  Google Scholar 

  22. Sutow, W., and Sullivan, M. Cyclophosphamide therapy in children with Ewing’s sarcoma. Cancer Chemother Rep 23: 55, 1962.

    PubMed  CAS  Google Scholar 

  23. Haddy, T., Whitaker, J., Vietti, T., et al. Clinical trials with cyclophosphamide (Cytoxan) in children with Wilms’ tumor - preliminary report. Cancer Chemother Rep 25: 81, 1962.

    PubMed  CAS  Google Scholar 

  24. Sweeney, M., Tuttle, A., Etteldorf, J., et al. Cyclophosphamide in the treatment of common neoplastic diseases of childhood. J Pediat 61: 702, 1962.

    Article  PubMed  CAS  Google Scholar 

  25. Brubaker, C., Sonley, K., Hyman, C., et al. Cyclophosphamide therapy of acute leukemia in children. Clin Res 10: 107, 1962.

    Google Scholar 

  26. Fernbach, D., Sutow, W., Thurman, W., et al. Clinical evaluation of cyclophosphamide. A new agent for the treatment of children with acute leukemia. JAMA 182: 30, 1962.

    CAS  Google Scholar 

  27. Hoogstratten, B. Cyclophosphamide in acute leukemia. Cancer Chemother Rep 16: 167, 1962.

    Google Scholar 

  28. Pinkel, D. Cyclophosphamide in children with cancer. Cancer 15: 42, 1962.

    Article  PubMed  CAS  Google Scholar 

  29. Steinberg, J., Haddy, T., Porter, F., et al. Clinical trials with cyclophosphamide in children with soft tissue sarcoma. Cancer Chemother Rep 28: 39, 1963.

    PubMed  CAS  Google Scholar 

  30. Rivers, S., Whittington, R., and Patno, M. Comparison of effect of cyclophosphamide and a placebo in treatment of multiple myeloma. Cancer Chemother Rep 29: 115, 1963.

    PubMed  CAS  Google Scholar 

  31. Solomon, J., Alexander, M., and Steinfeld, J. Cyclophosphamide. A clinical study. JAMA 183: 165, 1963.

    CAS  Google Scholar 

  32. Holcomb, T., Haggard, M., and Windmiller, J. Cyclophosphamide (NSC 26271) in uncommon malignant neoplasms in children. Cancer Chemother Rep 36: 73, 1964.

    PubMed  CAS  Google Scholar 

  33. Kaung, D., Whittington, R., and Patno, M. Treatment of chronic lymphocytic leukemia with chlorambucil and cyclophosphamide. Cancer Chemother Rep 39: 41, 1964.

    PubMed  CAS  Google Scholar 

  34. Papac, R., and Wood, D. Long term results achieved with the use of alkylating agents in malignant lymphoma and Hodgkin’s disease. Acta Un Int Contra Cancer 20: 377, 1964.

    CAS  Google Scholar 

  35. Korst, D., Frenkel, E., and Nixon, J. Multiple myeloma. Studies of mouse plasma cell tumor and human myeloma responsiveness to cyclophosphamide (Cytoxan). Ann Intern Med 60: 217, 1964.

    PubMed  CAS  Google Scholar 

  36. Frommeyer, W. Comparison of cyclophosphamide (Cytoxan) and uracil mustard (U-8344) in chronic granulocytic leukemia. Cancer 17: 288, 1964.

    Article  PubMed  Google Scholar 

  37. Korst, D., Clifford, G., Fowler, W., et al. Multiple myeloma - II. Analysis of cyclophosphamide therapy in 165 patients. JAMA 189: 758, 1964.

    Article  CAS  Google Scholar 

  38. Thurman, W., Fernbach, D., and Sullivan, M. Cyclophosphamide therapy in childhood neuroblastoma. New Eng J Med 270: 1336, 1964.

    Article  PubMed  CAS  Google Scholar 

  39. Rose, F., Meikle, R., and Lord, P. Endoxana (cyclophosphamide) in the treatment of intracerebral malignancy. J Neurol Neurosurg Psychiat 27: 470, 1964.

    Article  PubMed  CAS  Google Scholar 

  40. Foley, J., and Kennedy, B. Effect of cyclophosphamide on far-advanced neoplasia. Cancer Chemother Rep 34: 55, 1964.

    PubMed  CAS  Google Scholar 

  41. Fairley, G., and Healy, J. Hodgkin’s disease. In “Cyclophosphamide” (Fairley, G., and Simister, J., eds.), Williams and Wilkins Co., Baltimore; pp 1–4, 1965.

    Google Scholar 

  42. Matthias, J., Newall, J., Pugh, D., et al. Myeloma. In “Cyclophosphamide” (Fairley, G., and Simister, J., eds.), Williams and Wilkins Co., Baltimore; pp 7–15, 1965.

    Google Scholar 

  43. Fairley, G., and Hall, R. Leukemia. In “Cyclophosphamide” (Fairley, G., and Simister, J., eds.), Williams and Wilkins Co., Baltimore; pp 16–18, 1965.

    Google Scholar 

  44. Harrison, D., Espiner, H., and Glazebrook, G. Cyclophosphamide in head and neck cancer. In “Cyclophosphamide” (Fairley, G., and Simister, J., eds.), Williams and Wilkins Co., Baltimore; pp 48–55, 1965.

    Google Scholar 

  45. Ross, W., Jack, G., Helm, W., et al. Carcinoma of the lung. In “Cyclophosphamide” (Fairley, G., and Simister, J., eds.), Williams and Wilkins Co., Baltimore; pp 55–82, 1965.

    Google Scholar 

  46. Anderson, T. Carcinoma of the ovary. In “Cyclophosphamide” (Fairley, G., and Simister, J., eds.), Williams and Wilkins Co., Baltimore; pp 92–97, 1965.

    Google Scholar 

  47. Eton, B. Carcinoma of the ovary and uterus. In “Cyclophosphamide” (Fairley, G., and Simister, J., eds.), Williams and Wilkins Co., Baltimore; pp 98–100, 1965.

    Google Scholar 

  48. Mengel, C., Kelly, M., Carbone, P., et al. Clinical and biochemical effects of cyclophosphamide in patients with malignant carcinoid. Amer J Med 38: 396, 1965.

    Article  PubMed  CAS  Google Scholar 

  49. Wilson, W., and de la Garza, J. Systemic chemotherapy for CNS metastases of solid tumors. Arch Intern Med 115: 710, 1965.

    CAS  Google Scholar 

  50. Fox, M. The effect of cyclophosphamide on some urinary tract tumors. Brit J Urol 37: 399, 1965.

    Article  PubMed  CAS  Google Scholar 

  51. Barran, K., Helm, W., King, D. Bronchial carcinoma treated with nitrogen mustard and cyclophosphamide. Brit Med J 5463: 685, 1965.

    Article  Google Scholar 

  52. Burkitt, D., Hutt, M., and Wright, D. The African lymphoma. Preliminary observations on response to therapy. Cancer 18: 399, 1965.

    Article  PubMed  CAS  Google Scholar 

  53. Gordon, I., and McArthur, J. Thiotepa and cyclophosphamide in the treatment of advanced mammary cancer. Scot Med J 10: 27, 1965.

    PubMed  CAS  Google Scholar 

  54. Talley, R., Vaitkevicius, V., and Leighton, G. Comparison of cyclophosphamide and 5-fluorouracil in the treatment of patients with metastatic breast cancer. Clin Pharm Ther 6: 740, 1965.

    CAS  Google Scholar 

  55. McLean, R. Cyclophosphamide in the management of advanced bronchial carcinoma. Thorax 20: 555, 1965.

    Article  PubMed  CAS  Google Scholar 

  56. Skoog, W., and Adams, W. Clinical and metabolic investigations of eight cases of multiple myeloma during prolonged cyclophosphamide administration. Amer J Med 41: 76, 1966.

    Article  CAS  Google Scholar 

  57. Solidoro, A., Esteves, L., Castellano, C., et al. Chemotherapy of advanced cancer of the cervix. Experience in 55 cases treated with cyclophosphamide. Amer J Obstet Gyn 94: 208, 1966.

    CAS  Google Scholar 

  58. Solidoro, A., and Saenz, R. Effects of cyclophosphamide on 127 patients with malignant lymphoma. Cancer Chemother Rep 50: 265, 1966.

    PubMed  CAS  Google Scholar 

  59. Stutzman, L., and Ezdinli, E. Vinblastine sulfate vs cyclophosphamide in the therapy for lymphoma. JAMA 195: 173, 1966.

    CAS  Google Scholar 

  60. Hyman, G., and Cassileth, P. Efficacy of cyclophosphamide in the management of reticulum-cell sarcoma. Cancer 19: 1386, 1966.

    Article  PubMed  CAS  Google Scholar 

  61. Pierce, M., Shore, N., Sitarz, A., et al. Cyclophosphamide therapy in acute leukemia of childhood. Cancer 19: 1551, 1966.

    Article  PubMed  CAS  Google Scholar 

  62. Fernbach, D., Griffith, K., Haggard, M., et al. Chemotherapy of acute leukemia in childhood. New Eng J Med 275: 451, 1966.

    Article  PubMed  CAS  Google Scholar 

  63. Fernbach, D. Chemotherapy for acute leukemia in children: comparison of cyclophosphamide (NSC 26271) and 6-mercaptopurine (NSC 755). Cancer Chemother Rep 51: 381, 1967.

    Google Scholar 

  64. Holcomb, T. Cyclophosphamide (NSC 26271) in the treatment of acute leukemia in children. Cancer Chemother Rep 51: 389, 1967.

    Google Scholar 

  65. Sullivan, M. Cyclophosphamide therapy for children with generalized lymphoma and Hodgkin’s disease. Cancer Chemother Rep 51: 393, 1967.

    Google Scholar 

  66. Haggard, M. Cyclophosphamide in the treatment of children with malignant neoplasms. Cancer Chemother Rep 51: 403, 1967.

    Google Scholar 

  67. Thurman, W., and Donaldson, M. Cyclophosphamide therapy for children with neuroblastoma. Cancer Chemother Rep 51: 399, 1967.

    Google Scholar 

  68. Sutow, W. Cyclophosphamide in Wilms’ tumor and rhabdomyosarcoma. Cancer Chemother Rep 51: 407, 1967.

    Google Scholar 

  69. Choi, 0., English, A., Hilton, J., et al. Cyclophosphamide in the treatment of myelomatosis. Canad Med Assoc J 97: 1133, 1967.

    Google Scholar 

  70. Bergsagel, D., Robertson, G., and Hasselback, R. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses. Canad Med Assoc J 98: 532, 1968.

    PubMed  CAS  Google Scholar 

  71. Beck, R., and Boyes, D. Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide. Canad Med Assoc J 98: 539, 1968.

    PubMed  CAS  Google Scholar 

  72. Carbone, P., and Spurr, C. Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Cancer Res 28: 811, 1968.

    PubMed  CAS  Google Scholar 

  73. Jacobs, E., Peters, F., Luce, J., et al. Mechlorethamine HC1 and cyclophosphamide in the treatment of Hodgkin’s disease and the lymphomas. JAMA 203: 392, 1968.

    CAS  Google Scholar 

  74. Firat, D., and Olshin, S. Treatment of metastatic carcinoma of the female breast with combination of hormones and other chemotherapy. Cancer Chemother Rep 52: 743, 1968.

    PubMed  CAS  Google Scholar 

  75. Rivers, S., and Patno, M. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma. JAMA 207: 1328, 1969.

    Article  CAS  Google Scholar 

  76. Green, R., Humphrey, E., Close, H., et al. Alkylating agents in bronchogenic carcinoma. Amer J Med 46: 516, 1969.

    Article  PubMed  CAS  Google Scholar 

  77. Finklestein, J., Hittle, R., and Hammond, D. Evaluation of a high dose cyclophosphamide regimen in childhood tumors. Cancer 23: 1239, 1969.

    Article  PubMed  CAS  Google Scholar 

  78. Gold, G., Shnider, B., Salvin, L., et al. The use of mechlorethamine, cyclophosphamide, and uracil mustard in neoplastic disease: a cooperative study. J Clin Pharmacol New Drugs 10: 110, 1970.

    CAS  Google Scholar 

  79. Mendelson, D., Block, J., and Serpick, A. Effect of large intermittent doses of cyclophosphamide in lymphoma. Cancer 25: 715, 1970.

    Article  PubMed  CAS  Google Scholar 

  80. Smith, J., Ruttedge, F., Burns, B., et al. Systemic chemotherapy for carcinoma of the cervix. Amer J Obstet Gynec 97: 800, 1967.

    PubMed  CAS  Google Scholar 

  81. Decker, D., Malkasian, G., Mussey, E., et al. Cyclophosphamide. Evaluation in recurrent and progressive ovarian cancer. Amer J Obstet Gynec 97: 656, 1967.

    Google Scholar 

  82. Haddy, T., Nora, H., Sutow, W., et al. Cyclophosphamide treatment for metastatic soft tissue sarcoma. Amer J Dis Child 114: 301, 1967.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Cancer Institute, Bethesda, Maryland, USA

    Robert B. Livingston & Stephen K. Carter

Authors
  1. Robert B. Livingston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen K. Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1970 IFI/Plenum · New York-Washington-London

About this chapter

Cite this chapter

Livingston, R.B., Carter, S.K. (1970). Cyclophosphamide. In: Single Agents in Cancer Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1378-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1378-6_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1380-9

  • Online ISBN: 978-1-4684-1378-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation